FOXNews.com: Cancer trials show one year on Roche's Herceptin is best

FOXNews.com FOX News Network - We Report. You Decide.

Cancer trials show one year on Roche's Herceptin is best Oct 1st 2012, 11:47 Extending treatment with Roche's breast cancer drug Herceptin to two years from the one year current standard is not worth while, trial data showed on Monday, but shortening treatment to six months also looks unlikely to benefit patients

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions